← Leaderboards
Kathleen Schmeler
University Of Tx Md Anderson Can Ctr
$5,727,235
Attributed
$11,325,587
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,475,708 · 8
By mechanism
U54$3,646,648 · 2
R01$3,618,475 · 2
UH3$2,983,188 · 1
U01$2,124,467 · 1
T32$1,102,930 · 1
UH2$1,000,000 · 1
Top collaborators
- Rebecca Rae Richards-Kortum16 shared
- Vanderlei Bagnato6 shared
- Elizabeth Chiao6 shared
- Regis Kreitchmann6 shared
- Cesaltina Ferreira Lorenzoni6 shared
- Edna Viegas5 shared
- Pamela Soliman2 shared
- Anil K Sood2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Nicholas Navin$6,790,069
- Peter W Pisters$146,474
- Bing Yu$11,637,459
- Cesaltina Ferreira Lorenzoni$1,475,824
- Guojun Li$2,468,355
Others in their field
Top investigators on “Malignant Neoplasm Of Cervix Uteri”
- David Heimbrook · Leidos Biomedical Research, Inc.$177,328,706
- Philip J Disaia · University Of California Irvine$75,863,106
- Walter John Curran · Thomas Jefferson University$47,862,860
- Larry Arthur$27,902,757
- Norman Wolmark · Nsabp Foundation, Inc.$21,221,311
- T.-C. Wu · Howard University$18,468,441
Research focus
Malignant Neoplasm Of Cervix UteriWomanDiagnosisWomen&AposProgramsMalignant NeoplasmsLow And Middle-Income CountriesCessation Of LifeCancer EtiologyPoint Of CareWorld Health OrganizationScreeningCervical Cancer ScreeningCervicalMorbidity - Disease RateTechnologyRiceUniversitiesBiomedical EngineeringCostBrazilHuman Papilloma Virus InfectionCountryMortality
Grant awards (27)
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$647,289
U54 · FY2025 · CA · contact PI
Training of Academic Gynecologic Oncologists$515,659
T32 · FY2025 · CA
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$459,312
U01 · FY2025 · CA · contact PI
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$298,508
U01 · FY2025 · CA · contact PI
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$246,592
U54 · FY2025 · CA · contact PI
Admin Core$129,458
U54 · FY2025 · CA · contact PI
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$120,096
U54 · FY2025 · CA · contact PI
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$45,360
U54 · FY2025 · CA · contact PI
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$1,059,338
U54 · FY2024 · CA · contact PI
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$736,499
U01 · FY2024 · CA · contact PI
Training of Academic Gynecologic Oncologists$587,271
T32 · FY2024 · CA
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer$526,078
R01 · FY2024 · CA
Admin Core$169,950
U54 · FY2024 · CA · contact PI
The AVANÃO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV$1,031,446
U54 · FY2023 · CA · contact PI
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer$538,502
R01 · FY2023 · CA
Admin Core$197,119
U54 · FY2023 · CA · contact PI
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$630,148
U01 · FY2022 · CA · contact PI
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer$539,693
R01 · FY2022 · CA
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer$553,327
R01 · FY2021 · CA
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$695,265
R01 · FY2020 · CA · contact PI
Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer$614,528
R01 · FY2020 · CA
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical-Cancer Risk Reduction in HIV+ Women living in Mozambique$151,082
R01 · FY2020 · CA
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs$991,122
UH3 · FY2018 · CA · contact PI
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs$996,033
UH3 · FY2017 · CA · contact PI
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs$996,033
UH3 · FY2016 · CA · contact PI
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs$500,000
UH2 · FY2015 · CA · contact PI
Point-of-Care Diagnostic Tools to Improve Global Cervical Cancer Control Programs$500,000
UH2 · FY2014 · CA · contact PI